Professional Associations

Browse through the links below for news and information from some of the country's largest medical and gastroenterology organizations

American College of Gastroenterology
www.acg.gi.org: This professional and patient site offers access to ACG publications, online CME, practice guidelines, information on research grants and awards, patient education brochures and more.
American College of Physicians
www.acponline.org: This site is geared towards internists, with access to internal medicine journals, CME and clinical information.
American Medical Association
www.ama-assn.org: This site links to AMA policy, journals, information for physicians and more.
American Society for Gastrointestinal Endoscopy
www.asge.org: This site includes professional links to information on meetings, policy, news, endoscopic products, patient information and more.
The Society of American Gastrointestinal and Endoscopic Surgeons
www.sages.org: Find SAGES guidelines, statements, standards of practice, educational video library, job board, patient information brochures and more.
Society of Gastroenterology Nurses and Associates, Inc.
www.sgna.org: Provides education, research, advocacy and collaboration for gastroenterology and endoscopic nurses with information on scholarships, grants and awards, CE, lists of educational events and more.

Important Safety Information

PENTASA is indicated for the induction of remission and for the treatment of patients with mildly to moderately active ulcerative colitis.

PENTASA is generally well tolerated. In worldwide clinical trials (N>2100), the most common adverse events were diarrhea (3.4%), headache (2.0%), nausea (1.8%), abdominal pain (1.7%), dyspepsia (1.6%), vomiting (1.5%), and rash (1.0%). As with other mesalamine products, serious adverse events may occur. PENTASA is contraindicated in patients with a hypersensitivity to salicylates. Caution should be used in patients with impaired hepatic or renal function. Patients with pre-existing renal disease, increased BUN or serum creatinine, or proteinuria should be monitored during PENTASA therapy.